Where can I learn more about this study?
You can find more information about this study on the websites listed below. When a full report
of the study results is available, it also can be found here.
> www.clinicaltrials.gov Once you are on the website, type “NCT03877224”
into the search box and click “Search”.
> http://www.clinicaltrialsregister.eu Once you are on the website, click “Home and
Search”, then type “2018-003441-42” in the search box and click “Search”.
> www.AstraZenecaClinicalTrials.com Once you are on the website, type “D169EC00001”
into the search box, and click “Find a Study”.
Full Study Title: An International, Multicentre, Parallel-group, Randomised, Double-blind,
Placebo-controlled, Phase III Study Evaluating the effect of Dapagliflozin on Exercise Capacity in
Heart Failure Patients with Preserved Ejection Fraction (HFpEF)
AstraZeneca Protocol number: D169EC00001
National Clinical Trials number: NCT03877224
EudraCT number: 2018-003441-42
AstraZeneca sponsored this study and has its headquarters at Cambridge, UK.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants and their families belong to a large community of people who take
part in clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on
educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants
for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0_2021_04_30
16 | Clinical Study Results